ICO
Closed:

Novel Oral Therapeutics for the Treatment of Immunology and Inflammation Diseases

A multinational pharmaceutical company is seeking novel oral drug molecules for immunology and inflammation diseases. The modalities include oral small molecules, protein or RNA degraders, oral peptides, etc. Specifically, our client is most interested in novel oral therapeutics that act on clinically validated targets with biologic drugs in Phase 1 and beyond.

Approaches of Interest:

  • All immunology and inflammation diseases are of interest. Therapeutics that treat asthma, COPD, IPF and IBD are of highest priority
  • Modalities of interest include small molecules...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

  • Biotech Asset

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

  • Biotech Asset

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.